Nurse Practitioner, Family · Weslaco, TX
NPI
1952474397
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1116 E 8th St Ste 3
Weslaco, TX, 78596
Phone (956) 603-1555
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
250 services
Medicare patients, 2024
12
Average age 84
Drug cost, 2024
$5.5M
7,064 prescriptions
Company payments, 2025
$4,670
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pamela Lopez was code 99309 (snf e&m), 246 times for 12 patients. In total Pamela Lopez billed 250 services in 2 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 246 | 12 | $61.32 | $15K |
By year: 2022 $38K for 661 services; 2023 $43K for 646 services; 2024 $16K for 250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pamela Lopez prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 881 prescriptions and refills. In total Pamela Lopez wrote 7,064 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 881 | 1,323 | 193 | $1.4M |
| Atorvastatin Calcium Generic | 444 | 1,236 | 151 | $5,495 |
| Pioglitazone Hcl Generic | 410 | 1,173 | 148 | $6,254 |
| Tresiba Flextouch U-200 Insulin Degludec | 380 | 1,007 | 125 | $331K |
| Ozempic Semaglutide | 349 | 622 | 112 | $578K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 307 | 682 | 86 | $371K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 273 | 723 | 121 | $31K |
| Levothyroxine Sodium Generic | 257 | 751 | 95 | $2,949 |
| Jardiance Empagliflozin | 244 | 619 | 85 | $339K |
| Rosuvastatin Calcium Generic | 186 | 500 | 61 | $3,682 |
| Losartan Potassium Generic | 114 | 336 | 39 | $1,202 |
| Metformin Hcl Generic | 109 | 327 | 46 | $837 |
| Gabapentin Generic | 98 | 255 | 38 | $1,565 |
| Lisinopril Generic | 96 | 244 | 34 | $828 |
| Novolog Flexpen Insulin Aspart | 93 | 205 | 36 | $22K |
Brand drugs: 3,741 claims; generic drugs: 2,649 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela Lopez $4,670 ($4,670 in general payments such as food, travel and fees) from 24 companies. The largest payer was Novo Nordisk Inc with $552.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 8 | $552 |
| Abbott Laboratories ABT | 11 | $532 |
| Lilly USA, LLC LLY | 17 | $483 |
| Corcept Therapeutics CORT | 22 | $476 |
| Dexcom, Inc. DXCM | 8 | $395 |
| Ascensia Diabetes Care Us Inc. | 10 | $329 |
| Madrigal Pharmaceuticals MDGL | 4 | $293 |
| Amgen Inc. AMGN | 13 | $252 |
| Boston Scientific Corporation BSX | 3 | $177 |
| Radius Health, Inc. | 7 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.